Skip to main content

GMT Capital Corp

Source: SEC Form 13F · as of Mar 2026

GMT Capital Corp holds 8 biotech & pharma companies tracked by BioSniper, totaling $129.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

8

Total value held

$129.0M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Jazz Pharmaceuticals plc (JAZZ)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.